Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
Digital Therapeutics 2.0: The Evolving Role of Digital Therapeutics - Proceedings from the AMCP Partnership Forum
Webinar Recorded on Feb. 9, 2022
The role of digital therapies in preventing, managing, and treating medical conditions has evolved greatly in the past few years. AMCP held a multidisciplinary stakeholder forum on August 31 – September 1, 2021 to outline the key barriers and develop solutions to support the appropriate use and coverage of digital therapeutics in the health care system. Forum participants represented diverse sectors of the healthcare industry, including payers, pharmacy benefit managers (PBMs), integrated delivery systems, health economists and analysts, patient advocates, academicians, and digital therapeutic innovators; they explored the current market space for digital therapeutics, including the evidence and benefits of the products, their place in treating disease, and challenges patients face in accessing therapies. In addition, this group worked to identify challenges and payer needs related to the evidence required to ensure coverage of digital therapeutics.
Speakers:
- Theresa Juday, RPh
Director, Specialty Product Development
CVS Health - Danielle Massie, PharmD
Pharmacy Manager, Business Development
Moda Health - Jamie Van Iderstine
Senior Vice President, Client Engagement
Cyan Health
Related
This advisory group was active from March 2021-June 2022.
This advisory group was active from April 2021-March 2022.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
